These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7200466)

  • 1. DDS 100 mg daily, the cornerstone in the management of reversal reaction.
    van der Meulen J; Mock B
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):457-9. PubMed ID: 7200466
    [No Abstract]   [Full Text] [Related]  

  • 2. DDS 100 mg daily preventing permanent nerve damage in reversal reaction.
    Van der Meulen J
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):208-10. PubMed ID: 6249766
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy.
    Yawalkar SJ; Sanjana HB
    Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of "tile reaction" test for screening dapsone in urine.
    Irudaya Raj PP; Lilly L; Aschhoff M; Balakrishnan S
    Lepr India; 1983 Oct; 55(4):654-64. PubMed ID: 6668921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
    [No Abstract]   [Full Text] [Related]  

  • 9. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines.
    Lara CB
    Acta Leprol; 1978; (70):35-58. PubMed ID: 104537
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hansen's disease (leprosy).
    Wariyar B
    Nebr Med J; 1996 May; 81(5):147-8. PubMed ID: 8975147
    [No Abstract]   [Full Text] [Related]  

  • 13. Paper spot test and DDS/creatinine ratios in relation to treatment taken by leprosy patients.
    Balakrishnan S; Kumar A; Rozario JA; Thiagarajan M; Sirumban P
    Lepr India; 1983 Apr; 55(2):231-6. PubMed ID: 6632782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for prevention of borderline leprosy reactions by dapsone.
    Barnetson RS; Pearson JM; Rees RJ
    Lancet; 1976 Nov; 2(7996):1171-2. PubMed ID: 62998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal reaction to Hansen's disease.
    Jih MH; Kimyai-Asadi A; Levis WR
    J Drugs Dermatol; 2002 Jul; 1(1):70-1. PubMed ID: 12847760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of self administration of dapsone in urine by out-patients attending field clinics.
    Balakrishnan S; Christian M
    Lepr India; 1980 Apr; 52(2):249-51. PubMed ID: 7453139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Low doses of dapsone in the treatment of leprosy.
    Jopling WH
    Int J Lepr Other Mycobact Dis; 1972; 40(4):419. PubMed ID: 4677498
    [No Abstract]   [Full Text] [Related]  

  • 19. Standardized schemes for steroid treatment in ENL and reversal reactions.
    Imkamp FM
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):313-7. PubMed ID: 4020218
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.